BYSTOLIC DIN 02399024
Status: Marketed
Holder: ABBVIE CORPORATION
Molecule: NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C07AB12 NEBIVOLOL |
| Original market date | 02-Apr-2013 |
| Current status date | 02-Jul-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02492520 | APO-NEBIVOLOL | APOTEX INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 2.5 MG | Approved |
| 02492539 | APO-NEBIVOLOL | APOTEX INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 5 MG | Approved |
| 02492547 | APO-NEBIVOLOL | APOTEX INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 20 MG | Approved |
| 02398990 | BYSTOLIC | ABBVIE CORPORATION | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 2.5 MG | Marketed |
| 02399008 | BYSTOLIC | ABBVIE CORPORATION | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 5 MG | Marketed |
| 02399016 | BYSTOLIC | ABBVIE CORPORATION | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 10 MG | Marketed |
| 02543508 | JAMP NEBIVOLOL | JAMP PHARMA CORPORATION | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 5 MG | Marketed |
| 02543516 | JAMP NEBIVOLOL | JAMP PHARMA CORPORATION | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 20 MG | Approved |
| 02548704 | PRZ-NEBIVOLOL | PHARMARIS CANADA INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 2.5 MG | Marketed |
| 02548712 | PRZ-NEBIVOLOL | PHARMARIS CANADA INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 5 MG | Marketed |
| 02548720 | PRZ-NEBIVOLOL | PHARMARIS CANADA INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 10 MG | Marketed |
| 02548739 | PRZ-NEBIVOLOL | PHARMARIS CANADA INC | Tablet | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) 20 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 29410 | 2022-11-08 | New Drug Submission (NDS) | Administrative: Merger/Buy-out |
| 13962 | 2012-12-21 | New Drug Submission (NDS) |